Healthcare -
Biotechnology - NASDAQ - US
$ 0.8465
3.31 %
$ 306 M
Market Cap
-1.14
P/E
Price Target
Average
608.80%
Revenue Forecast
Estimate
439.17%
EBIT
Estimate
8.62%
Net Income
Estimate
54.26%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Lexicon Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for LXRX of $6 , with forecasts ranging from
a
low of
$6 to a high of $6 .
LXRX Lowest Price Target
Wall Street Target
6 USD
608.80%
LXRX Average Price Target
Wall Street Target
6 USD
608.80%
LXRX Highest Price Target
Wall Street Target
6 USD
608.80%
REVENUE FORECAST
Revenue Forecast Chart LXRX
EBIT FORECAST
EBIT Forecast Chart LXRX
NET INCOME FORECAST
Net Income Chart LXRX